Khurwolah MR, Meng HY, Wang YS, Wang LS, Kong XQ. Safety and efficacy of frequency-domain optical coherence tomography in evaluating and treating intermediate coronary lesions. World J Cardiol 2018; 10(11): 222-233 [PMID: 30510639 DOI: 10.4330/wjc.v10.i11.222]
Corresponding Author of This Article
Xiang-Qing Kong, MD, PhD, Full Professor, Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. kongxq@njmu.edu.cn
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Clinical Trials Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Nov 26, 2018; 10(11): 222-233 Published online Nov 26, 2018. doi: 10.4330/wjc.v10.i11.222
Table 1 Baseline characteristics of the optical coherence tomography study population
Variable
Overall (n = 64)
OCT-guided PCI (n = 38)
OCT-guided OMT (n = 26)
P-value
Age (yr)
63.17 ± 9.68
63.42 ± 9.88
62.81 ± 9.56
0.806
Male (%)
43 (67.2)
25 (65.8)
18 (69.2)
0.773
Diabetes mellitus (%)
10 (15.6)
7 (18.4)
3 (11.5)
0.693
Hypertension (%)
39 (60.9)
22 (57.9)
17 (65.4)
0.546
Discharge treatment
Aspirin (%)
64 (100)
38 (100)
26 (100)
1
P2Y12 inhibitor (%)
59 (92.2)
38 (100)
25 (96.1)
0.406
Statin (%)
64 (100)
38 (100)
26 (100)
1
Beta-blocker (%)
29 (45.3)
19 (50)
10 (38.5)
0.362
ACE-I/ARB (%)
33 (51.6)
23 (60.5)
10 (38.5)
0.083
CCB (%)
24 (37.5)
13 (34.2)
11 (42.3)
0.511
Nitrates (%)
36 (56.2)
21 (55.3)
15 (57.7)
0.847
Admission diagnosis
0.068
Stable angina (%)
7 (10.9)
4 (10.5)
3 (11.5)
Unstable angina (%)
53 (82.8)
34 (89.5)
19 (73.1)
NSTEMI (%)
2 (3.1)
0 (0)
2 (7.7)
STEMI (%)
2 (3.1)
0 (0)
2 (7.7)
ICL vessel
0.671
LAD (%)
37 (57.8)
21 (55.3)
16 (61.5)
LCX (%)
12 (18.8)
6 (15.8)
6 (23.1)
RCA (%)
15 (23.4)
10 (26.3)
5 (19.2)
Table 2 Two-dimensional quantitative coronary angiography findings pre-optical coherence tomography in the percutaneous coronary intervention and optimal medical therapy groups
Variable
OCT-guided PCI (n = 38)
OCT-guided OMT (n = 26)
P-value
Reference area, mm2
7.91 (5.61-10.45)
7.97 (6.01-11.16)
0.538
Minimum luminal area, mm2
1.97 (1.37-2.80)
2.40 (1.73-3.82)
0.029
Area stenosis %
74.02 ± 6.43
67.77 ± 6.44
0.001
Table 3 Frequency-domain optical coherence tomography findings in the percutaneous coronary intervention and optimal medical therapy groups
Table 5 Clinical outcomes at 12 mo follow-up n (%)
Variable
OCT-guided PCI (n = 38)
OCT-guided OMT (n = 26)
P-value, overall = 0.634
Myocardial infarction
1 (2.6)
0
1
Target lesion revascularisation
1 (2.6)
0
1
Re-angina
13 (34.2)
8 (30.8)
0.603
Re-hospitalisation
3 (7.9)
2 (7.7)
0.920
Minor bleeding events
5 (13.2)
1 (3.8)
0.427
Citation: Khurwolah MR, Meng HY, Wang YS, Wang LS, Kong XQ. Safety and efficacy of frequency-domain optical coherence tomography in evaluating and treating intermediate coronary lesions. World J Cardiol 2018; 10(11): 222-233